<DOC>
	<DOC>NCT01287988</DOC>
	<brief_summary>The primary objective of this study is to assess visual function in up to 44 patients who have previously participated in either of the placebo controlled, ocriplasmin Phase III studies (TG-MV-006 or TG-MV-007).</brief_summary>
	<brief_title>Follow-up Study to Assess Visual Function in Subset of Patients Who Have Previously Participated in the TG-MV-006 and TG-MV-007 Ocriplasmin Studies</brief_title>
	<detailed_description>Non-interventional follow up study consisting of 1 patient visit to perform assessments to assess long term visual function</detailed_description>
	<criteria>Written informed consent obtained from the patient prior to inclusion in the followup study Previous participation in either of the placebo controlled, ocriplasmin Phase III studies (TGMV006 or TGMV007)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>